UNICA IRIS Institutional Research Information System

CADEDDU DESSALVI, CHRISTIAN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 303.107
NA - Nord America 8.648
AS - Asia 1.805
AF - Africa 943
OC - Oceania 51
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 7
Totale 314.581
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 300.797
US - Stati Uniti d'America 8.562
CN - Cina 850
ZA - Sudafrica 761
UA - Ucraina 754
SE - Svezia 595
SG - Singapore 291
GB - Regno Unito 278
DE - Germania 214
IN - India 209
FI - Finlandia 195
BD - Bangladesh 98
VN - Vietnam 94
FR - Francia 86
CA - Canada 64
BE - Belgio 56
KE - Kenya 54
ZM - Zambia 37
SA - Arabia Saudita 34
NL - Olanda 28
PK - Pakistan 28
RU - Federazione Russa 26
UG - Uganda 24
AU - Australia 23
PH - Filippine 22
TR - Turchia 22
KR - Corea 20
NP - Nepal 17
BR - Brasile 16
ID - Indonesia 16
HK - Hong Kong 15
AE - Emirati Arabi Uniti 13
NG - Nigeria 13
PL - Polonia 13
FJ - Figi 12
MY - Malesia 12
GH - Ghana 11
IR - Iran 11
ES - Italia 9
MW - Malawi 9
ZW - Zimbabwe 9
PT - Portogallo 8
TZ - Tanzania 8
AT - Austria 7
EU - Europa 7
KW - Kuwait 7
NZ - Nuova Zelanda 7
TW - Taiwan 7
BG - Bulgaria 6
JP - Giappone 6
LK - Sri Lanka 6
RO - Romania 6
TH - Thailandia 6
IE - Irlanda 5
LC - Santa Lucia 5
PG - Papua Nuova Guinea 5
CH - Svizzera 4
CY - Cipro 4
GR - Grecia 4
KH - Cambogia 4
PR - Porto Rico 4
SB - Salomone, isole 4
SI - Slovenia 4
CL - Cile 3
LS - Lesotho 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CU - Cuba 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
MM - Myanmar 2
MU - Mauritius 2
MZ - Mozambico 2
OM - Oman 2
SZ - Regno dello Swaziland 2
AZ - Azerbaigian 1
BW - Botswana 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GD - Grenada 1
GP - Guadalupe 1
IM - Isola di Man 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
MT - Malta 1
MX - Messico 1
NA - Namibia 1
QA - Qatar 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 314.580
Salva come PNG Salva come JPEG
Città #
Cagliari 204.322
Uta 95.958
Fairfield 1.109
Woodbridge 947
Houston 640
Chandler 619
Ashburn 583
Ann Arbor 564
Boardman 516
Wilmington 485
Nyköping 452
Seattle 422
Jacksonville 400
Cambridge 390
Dearborn 246
Johannesburg 190
Nanjing 158
Santa Clara 153
Singapore 144
Beijing 119
Boston 108
Dong Ket 90
Helsinki 84
Shanghai 84
Pretoria 70
Cape Town 68
San Diego 67
Redwood City 49
Guangzhou 48
Nanchang 48
Toronto 47
New York 46
Shenyang 45
London 39
Milan 39
Hebei 37
Lusaka 37
Brussels 32
Tianjin 32
Changsha 29
Durban 29
Orange 27
Jiaxing 25
Nairobi 24
Los Angeles 23
Mountain View 22
Norwalk 20
Auburn Hills 19
Amsterdam 18
Jinan 18
Sassari 18
Zhengzhou 18
Seoul 17
Washington 17
Atlanta 16
Kunming 16
Phoenix 16
Dhaka 15
Verona 15
Hong Kong 13
Hefei 12
Mumbai 12
Pune 12
Wuhan 12
Kampala 11
San Mateo 11
Accra 10
Augusta 10
Saint Petersburg 10
Torino 10
Tzaneen 10
Boksburg 9
Chicago 9
Ningbo 9
Suva 9
Borås 8
Caserta 8
Dar es Salaam 8
Genova 8
Guwahati 8
Port Elizabeth 8
Rome 8
Sestu 8
Ankara 7
Davao 7
Harare 7
Indore 7
Lilongwe 7
Riyadh 7
Taizhou 7
Capannori 6
Duncan 6
Falls Church 6
Hounslow 6
Karachi 6
Katowice 6
Kolkata 6
Kuwait City 6
Lucknow 6
Monmouth Junction 6
Totale 310.231
Salva come PNG Salva come JPEG
Nome #
Non-invasive estimation of stroke volume during exercise from oxygen in heart failure patients 74.978
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 12.750
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.271
Metabolomic approach to profile functional and metabolic changes in heart failure 4.123
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.061
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.780
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.452
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.394
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.365
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.315
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.216
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.184
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 2.991
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 2.932
Metabolomics and heart failure: a new and promising scientific approach 2.878
Coronary Artery Disease 2.823
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.724
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.722
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.652
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.631
Metabolomics, a promising approach to translational research in cardiology 2.581
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.574
Sex-related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model 2.448
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.403
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.392
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.290
null 2.234
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 2.208
null 2.190
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.150
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.142
Women-specific predictors of cardiovascular disease risk - new paradigms 2.082
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.063
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.061
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.059
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.040
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.039
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.032
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.021
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 1.995
Antineoplastic drug-induced cardiotoxicity: A redox perspective 1.993
The need of a gender-corrected evidence based medicine 1.969
Gender differences in the development of cardiac complications: A multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up 1.908
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 1.864
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.851
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.840
Current views on anthracycline cardiotoxicity 1.816
Arterial hypertension in the female world: Pathophysiology and therapy 1.798
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.785
Ultrasound examination for the detection of simulated periapical bone lesions in bovine mandibles: an ex vivo study 1.785
A novel desmoplakin mutation associated with left dominant arrhythmogenic cardiomyopathy and cutaneous phenotype 1.782
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.724
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.707
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.694
Multimodality imaging diagnosis of multiple ventricular thrombosis and massive stroke after gemcitabine and cisplatin chemotherapy for Urothelial Cancer 1.690
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.689
Gender differences in cardiology: is it time for new guidelines? 1.671
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 1.670
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 1.599
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.598
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.595
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.584
Role of biomarkers in monitoring antiblastic cardiotoxicity 1.557
Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib 1.546
Evaluation of left atrial appendage function and thrombi in patients with atrial fibrillation: from transthoracic to real time 3D transesophageal echocardiography 1.510
High prevalence of interatrial septal aneurysm in young adults who were born preterm 1.503
Subclinical contractility impairment in HIV-infected patients varies according to class of antiretroviral drugs 1.500
null 1.489
Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs 1.488
null 1.471
To be or not to be resilient in familial hypercholesterolaemia: implications for the management 1.444
The different role of sex hormones on female cardiovascular physiology and function: not only oestrogens 1.420
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.419
Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue? 1.413
Vascular damage-Coronary artery disease 1.413
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.399
Trastuzumab-induced early cardiac dysfunction assessed by speckle tracking echocardiography: correlation with chronic inflammation and oxidative stress markers 1.384
Antiinflammatory therapy with canakinumab for atherosclerotic disease 1.379
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: Role of echocardiography 1.371
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 1.367
Early Ventricular Dysfunction in Type II Diabetes: Role of Metabolic Unbalance 1.342
Altered transmural contractility in women affected by cardiac X syndrome 1.325
Metabolomics: a new era in cardiology? 1.256
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 1.241
null 1.234
Time-to-balloon dependence of coronary flow velocity reserve after primary angioplasty in patients with anterior acute myocardial infarction 1.225
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.217
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology 1.214
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects 1.208
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.207
Consensus: Screening e terapia della cardiopatia ischemica nel paziente diabetico 1.180
Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate 1.125
Significant QT interval prolongation and long QT in young adult ex-preterm newborns with extremely low birth weight 1.118
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.103
Relationship between high values of HOMA-IR and cardiovascular response to metformin 1.065
null 1.054
Mortality for pancreatic cancer among aluminium smelter workers in Sardinia, Italy 1.025
Trastuzumab induced-early cardiac disfunction assessed with TDI: correlation with biological markers of chronic inflammation and oxidative stress. 985
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 949
null 944
Totale 277.948
Salva come PNG Salva come JPEG
Categoria #
all - tutte 361.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 361.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029.547 0 0 0 0 11.859 8.349 4.503 1.064 698 798 806 1.470
2020/202153.292 1.697 2.127 2.112 13.090 10.736 6.372 4.361 3.509 1.452 2.874 2.835 2.127
2021/202211.512 1.423 722 575 1.132 887 739 551 701 1.216 1.068 1.201 1.297
2022/202316.778 1.663 2.553 2.364 1.487 1.426 1.398 717 1.151 1.126 885 1.277 731
2023/202419.170 981 726 751 1.407 1.973 3.243 3.007 1.263 1.178 1.252 1.720 1.669
2024/2025123.593 9.408 11.930 82.429 18.180 1.646 0 0 0 0 0 0 0
Totale 315.232